ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

August 18, 1989

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989

NCCS Networker Volume 5 Issue 1, Winter 1991

January 13, 1991

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978